作者丨唐婧 编辑丨曾芳 （图源：新华社） 创新产品 深圳，这座从改革浪潮中走来的城市，已崛起为一处活力奔涌的科创高地。 作为创新之城，深圳平均每平方公里拥有12家国家高新技术企业，密度居全国各城市第 一；培育了超1300家专精特新"小巨人"企业，连续三年新增数量居全国各城市第一；全社 会研发投入占GDP比重达6.67%，跃居全国大中城市第一。 在这幅生机勃勃的创新图景背后，一套"股贷债保汇"联动、覆盖企业全生命周期的科技金融 服务体系，正悄然为每一次研发突破、每一轮产业跃升注入源头活水。 从"腾飞贷"为高成长企业注入续航动力，到"科技初创通"为早期项目点亮星火；从"科汇 通"便利深港科研资金流动，再到债市"科技板"引导长期资本流向硬科技前沿—— 深圳的科 技金融服务体系，已从单一的资金供给者，转型为贯穿创新全链条的"陪跑者"与"共建 者"。 这不仅提升了科技型中小企业的融资可得性，更推动金融资源更早、更精准地流向人工智 能、半导体、生物医药等关键核心技术领域，为建设具有全球重要影响力的产业科技创新中 心筑牢金融基石。截至2025年10月末，深圳科技贷款余额已突破2.2万亿元，科技创新债券 发行规模居全国前列， ...

Group 1 - China's actual use of foreign investment increased by 26.1% year-on-year in November, with a total of 61,207 new foreign-invested enterprises established in the first 11 months, marking a 16.9% increase [1] - By the end of June this year, China's actual use of foreign investment during the "14th Five-Year Plan" period reached $708.73 billion, achieving its target six months ahead of schedule [1] - The resilience and improving structure of China's foreign investment attraction are evident, making it a favored destination for foreign capital [1] Group 2 - In the first 11 months of this year, actual foreign investment in China's high-tech industries reached 221.26 billion yuan, significantly contributing to the total foreign investment [2] - The e-commerce service industry, medical instruments and equipment manufacturing, and aerospace manufacturing saw foreign investment growth rates of 127%, 46.5%, and 41.9% respectively, indicating a shift towards higher-quality investment [2] - Foreign companies are increasingly recognizing opportunities in China, with significant investments in artificial intelligence, new energy, biomedicine, and green transformation sectors [2] Group 3 - The core attractions for foreign investment in China include an open innovation ecosystem, a complete industrial system, and rich application scenarios [3] - From 2013 to 2023, R&D expenditures by multinational companies in China increased by 86.5%, reflecting a shift from technology transfer to joint R&D and co-building industrial ecosystems [3] - The "14th Five-Year Plan" suggests new deployments to create new advantages in attracting foreign investment, with an improving business environment and high-quality development expected to provide broader opportunities for foreign enterprises [3]

Group 1 - China's actual use of foreign investment increased by 26.1% year-on-year in November, with a total of 61,207 new foreign-invested enterprises established in the first 11 months, marking a 16.9% increase [1] - By the end of June, China's actual use of foreign investment during the 14th Five-Year Plan period reached $708.73 billion, achieving its $700 billion target six months ahead of schedule [1] - The resilience and improving structure of foreign investment in China are evident, making it a favored destination for foreign capital despite global challenges [1] Group 2 - In the first 11 months, actual foreign investment in China's high-tech industries reached 221.26 billion yuan, significantly contributing to the total foreign investment [2] - The e-commerce services, medical instruments manufacturing, and aerospace equipment manufacturing sectors saw foreign investment growth rates of 127%, 46.5%, and 41.9%, respectively [2] - Foreign companies are increasingly recognizing opportunities in China, with significant investments in artificial intelligence, new energy, biomedicine, and green transformation sectors [2] Group 3 - The core attractions for foreign investment in China include an open innovation ecosystem, a complete industrial system, and rich application scenarios [3] - From 2013 to 2023, R&D expenditures by multinational companies in China increased by 86.5%, reflecting a shift from technology transfer to joint R&D and co-building industrial ecosystems [3] - Companies like Schneider Electric and Bayer are leveraging China's innovation capabilities, with significant contributions to global product development and market applications [3]

央视网消息：据教育部网站消息，近日，新修订的《博士硕士学位授予资格审核办法》（以下简称《办 法》）正式印发。教育部学位管理与研究生教育司负责人就《办法》有关问题回答了记者提问。 1.问：本次《办法》修订的背景是什么？ 答：党中央高度重视研究生教育和学科专业设置调整优化。博士硕士学位授予资格审核，是国务院学位 委员会依法审批学位授予资格的重要事项，是推进研究生教育学科专业调整优化和高层次人才自主培养 的重要抓手。自1980年《中华人民共和国学位条例》颁布以来，国务院学位委员会集中开展了14批次学 位授予资格审核，并支持学位授予单位按条件和程序动态调整、自主审核增设和撤销学位授予点。截至 目前，全国共有博士学位授予单位504个、硕士学位授予单位863个，学科专业结构不断优化，高层次人 才自主培养能力不断提升。 《办法》是国务院学位委员会、省级学位委员会开展学位授予资格审核工作的重要依据。本次对《办 法》进行修订，主要是出于两方面考虑。一是落实党中央决策部署。党的二十届三中、四中全会对学科 专业设置作出重要部署，《教育强国建设规划纲要（2024—2035年）》《高等教育学科专业设置调整优 化行动方案（2025—20 ...

Group 1 - The core viewpoint of the news is that Shutaishen's stock has shown significant volatility, with a year-to-date increase of 275.17% and recent fluctuations in trading volume and price [1][2] - As of December 25, Shutaishen's stock price was 27.80 yuan per share, with a total market capitalization of 13.282 billion yuan [1] - The company has experienced a net outflow of main funds amounting to 23.4642 million yuan, with large orders showing a buy-sell imbalance [1] Group 2 - Shutaishen's main business involves the research, production, and sales of biological products and some chemical drugs, with the primary revenue sources being the injection of mouse nerve growth factor (59.17%) and compound polyethylene glycol electrolyte powder (33.19%) [1] - As of September 30, the company reported a revenue of 181 million yuan for the first nine months of 2025, a year-on-year decrease of 30.82%, and a net profit attributable to shareholders of -30.6895 million yuan, a decrease of 227.71% [2] - The company has not distributed any dividends in the last three years, with a total payout of 771 million yuan since its A-share listing [3]

近日，新修订的《博士硕士学位授予资格审核办法》（以下简称《办法》）正式印发。教育部学位管理 与研究生教育司负责人就《办法》有关问题回答了记者提问。 1.问：本次《办法》修订的背景是什么？ 答：党中央高度重视研究生教育和学科专业设置调整优化。博士硕士学位授予资格审核，是国务院学位 委员会依法审批学位授予资格的重要事项，是推进研究生教育学科专业调整优化和高层次人才自主培养 的重要抓手。自1980年《中华人民共和国学位条例》颁布以来，国务院学位委员会集中开展了14批次学 位授予资格审核，并支持学位授予单位按条件和程序动态调整、自主审核增设和撤销学位授予点。截至 目前，全国共有博士学位授予单位504个、硕士学位授予单位863个，学科专业结构不断优化，高层次人 才自主培养能力不断提升。 《办法》是国务院学位委员会、省级学位委员会开展学位授予资格审核工作的重要依据。本次对《办 法》进行修订，主要是出于两方面考虑。一是落实党中央决策部署。党的二十届三中、四中全会对学科 专业设置作出重要部署，《教育强国建设规划纲要（2024—2035年）》《高等教育学科专业设置调整优 化行动方案（2025—2027年）》等文件提出学科专业设 ...

Group 1 - The core viewpoint of the news is that Zhixiang Jintai has shown a significant increase in stock price and trading activity, indicating positive market sentiment towards the company [1] - As of December 25, Zhixiang Jintai's stock price rose by 2.02% to 26.79 CNY per share, with a total market capitalization of 9.823 billion CNY [1] - The company has experienced a year-to-date stock price increase of 6.78%, with a recent 5-day increase of 2.25%, although it has seen a decline of 19.65% over the past 60 days [1] Group 2 - For the period from January to September 2025, Zhixiang Jintai reported a revenue of 208 million CNY, reflecting a year-on-year growth of 1562.05% [2] - The company recorded a net profit attributable to shareholders of -333 million CNY, which represents a year-on-year increase of 39.12% [2] - As of September 30, 2025, the number of shareholders increased by 7.75% to 12,600, while the average number of circulating shares per shareholder decreased by 7.19% to 9,231 shares [2]

机构持仓方面，截止2025年9月30日，诺诚健华十大流通股东中，富国精准医疗灵活配置混合A （005176）位居第六大流通股东，持股1215.49万股，相比上期减少42.71万股。万家优选（161903）位 居第七大流通股东，持股1000.00万股，为新进股东。平安医疗健康混合A（003032）位居第八大流通股 东，持股862.66万股，为新进股东。工银前沿医疗股票A（001717）位居第九大流通股东，持股800.00 万股，为新进股东。汇添富创新医药混合A（006113）位居第十大流通股东，持股686.03万股，相比上 期减少74.34万股。中欧医疗健康混合A（003095）、鹏华医药科技股票A（001230）、易方达医疗保健 行业混合A（110023）退出十大流通股东之列。 诺诚健华今年以来股价涨74.35%，近5个交易日跌2.68%，近20日跌17.30%，近60日跌23.75%。 责任编辑：小浪快报 12月25日，诺诚健华盘中下跌2.01%，截至10:06，报21.41元/股，成交5115.47万元，换手率0.88%，总 市值377.81亿元。 诺诚健华所属申万行业为：医药生物-化学制药-化学制剂。所 ...

深圳在跨境投融资便利化上的又一关键表态。 从允许做升级为主动推广和深化，出台13年后，深圳的合格境外有限合伙人境内投资制度，将迎来更大 的调整完善。 12月23日，深圳市政府印发《深圳市进一步加大吸引和利用外资实施办法》（下称"办法"），提出深入 实施合格境外有限合伙人（QFLP）境内投资试点，加大QFLP总量管理制度经验推广，并支持符合条件 的基金管理企业发起设立由境外合伙人参与、以非公开方式募集并在境内开展投资活动的私募投资基 金。 这被视为深圳在跨境投融资便利化上的又一关键表态。 在全国范围内，QFLP已进入"多地赛跑"阶段，资本正加速流向人工智能、生物医药等硬科技赛道。 为何QFLP规则近年不断深化？原因是外资对中国科创机遇的迫切需求，与中国通过制度创新回应关切 的双向互动。从解决境外投资流程繁琐、资金使用不便的痛点，到拓宽至更多市场领域，QFLP正从单 一的引资通道，演进为连接全球资本与本土科创企业、推动产业升级与地方经济发展的重要桥梁。 深入实施QFLP试点 这一举措亦与国家层面的金融开放导向同频共振。24日，央行等八部门印发《关于金融支持加快西部陆 海新通道建设的意见》提出，探索境内外金融市场互 ...

Group 1 - The company, Xilong Science, primarily engages in the research, production, and sales of chemical reagents, as well as the production and sales of raw pharmaceuticals and food additives [2] - The company is also involved in the trade of certain chemical raw materials [2] - The main application areas for the company's products include semiconductors, new materials, biomedicine, petrochemicals, and new energy industries [2]